DEA Extends Temporary Status of Synthetic Opioid in Schedule I, Proposes Permanent Listing
The Drug Enforcement Administration is extending for one more year the temporary listing of beta-hydroxythiofentanyl in schedule I of the Controlled Substances Act, it said. The synthetic opioid, first temporarily listed in 2016, will now remain listed in schedule I…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
until May 12, 2019. DEA also issued a proposed rule to permanently list beta-hydroxythiofentanyl in schedule I, with comments due June 11. Substances may only be temporarily listed under the CSA for three years.